Pain in Alzheimer’s Disease: Disrupted Multilevel Integration of Nociception, Affective Processing and Clinical Expression Across Clinical and Preclinical Evidence
Life · 21.05.2026 · 16 (5) · 860
DOI: 10.3390/life16050860 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 21.05.2026. Verfasst von Gabriela-Dumitrita Stanciu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Research and Development Center for Experimental Medicine "Prof. Ostin C. Mungiu"-CEMEX, Grigore T. Popa University of Medicine and Pharmacy…. Die Arbeit nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by a grant of the Ministry of Research, Innovation and Digitization, CNCS-UEFISCDI, project number PN-IV-P2-2.1-TE-2023-0879, within PN…, Ministry of Research, Innovation and Digitization.
Themen: Demenz
Abstract (Originalsprache)
Pain is a multidimensional experience arising from the integration of nociceptive signals with affective, cognitive and behavioral processes. In Alzheimer’s disease (AD), pain assessment remains challenging, as reduced self-reported pain is frequently observed despite exposure to potentially painful conditions, suggesting altered processing rather than its absence. Emerging evidence indicates that pain in AD is characterized by a disruption of coordination among sensory detection, affective experience and clinical expression. Within this framework, nociceptive input may remain partially preserved, while its integration into emotionally meaningful and behaviorally coherent responses is compromised. Clinical studies report reduced self-report alongside observable indicators of discomfort, including agitation, withdrawal and affective disturbances. In parallel, preclinical models demonstrate preserved reflexive responses but altered affective-motivational processing. These alterations are associated with neuroinflammatory processes, synaptic dysfunction, large-scale network disconnection and changes in neuromodulatory systems involved in affective pain regulation, ultimately disrupting the integration of nociceptive signals within limbic and cortical networks. Taken together, this review integrates clinical and preclinical evidence to characterize pain in AD as a disruption of multilevel integration linking nociception, affective processing and clinical expression, with important implications for pain assessment strategies that extend beyond self-report to incorporate behavioral and translational approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Advanced Research and Development Center for Experimental Medicine "Prof. Ostin C. Mungiu"-CEMEX, Grigore T. Popa University of Medicine and Pharmacy Iasi, 700454 Iasi, Romania.
- Department of Pharmacology, Clinical Pharmacology and Algesiology, Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.
ORCID-Profile: Gabriela-Dumitrita Stanciu, Ivona Costachescu, Raluca-Maria Gogu, Bogdan-Ionel Tamba
Förderung
- This work was supported by a grant of the Ministry of Research, Innovation and Digitization, CNCS-UEFISCDI, project number PN-IV-P2-2.1-TE-2023-0879, within PN…
- Ministry of Research, Innovation and Digitization
Zitieren
APA
Stanciu, G. D., Costachescu, I., Gogu, R. M., & Tamba, B. I. (2026). Pain in Alzheimer’s Disease: Disrupted Multilevel Integration of Nociception, Affective Processing and Clinical Expression Across Clinical and Preclinical Evidence. Life, 16(5), 860. https://doi.org/10.3390/life16050860
Vancouver
Stanciu GD, Costachescu I, Gogu RM, Tamba BI. Pain in Alzheimer’s Disease: Disrupted Multilevel Integration of Nociception, Affective Processing and Clinical Expression Across Clinical and Preclinical Evidence. Life. 2026;16(5):860. doi:10.3390/life16050860
BibTeX
@article{Stanciu2026,
author = {Stanciu, Gabriela-Dumitrita and Costachescu, Ivona and Gogu, Raluca-Maria and Tamba, Bogdan-Ionel},
title = {Pain in Alzheimer’s Disease: Disrupted Multilevel Integration of Nociception, Affective Processing and Clinical Expression Across Clinical and Preclinical Evidence},
journal = {Life},
year = {2026},
volume = {16},
number = {5},
pages = {860},
doi = {10.3390/life16050860}
}
EUVIMED